‍

As 2026 approaches, orthopedic surgery faces what Dr. Ronald Gardner describes as a "sustainability test" driven by rising labor costs, "quiet" reimbursement cuts to RVUs, and an ever-mounting administrative burden.

At RegenMed, we believe the only way to pass this test is to bridge the "Inference Gap" — moving away from the probabilistic guesses of billing-code data and toward Deterministic Evidence captured directly by the treating physician.

Here is how we are partnering with orthopedic leaders to reclaim the evidence-based "Practice of Medicine":

1. Stop the Revenue Erosion

While traditional production revenue cycles are down per unit of work, RegenMed’s Dividend Model transforms clinical documentation into a high-margin asset.  By minting "Ground Truth" at the point of care, we repatriate 75–85% of net data license fees back to the clinical source, creating a sustainable research and revenue engine.

2. Reclaim Scientific Sovereignty

Dr. Gardner notes that research has historically not focused on identifying when fewer interventions can deliver equivalent outcomes.  RegenMed provides the infrastructure for Scientific Sovereignty, allowing surgeons to own their data and define the standards of their specialty — proving when conservative care is as effective as surgery and when high-cost procedures are clinically justified.

3. Treat the Patient, Not the X-Ray

Customizing care to a patient’s life — not just their imaging — requires having multiple, validated treatment options available.  Our Circle Datasets provide the high-fidelity evidence needed to validate individualized care pathways, ensuring that the "value" in value-based care is determined by actual clinical results, not administrative algorithms.

Orthopedic innovation is only sustainable when clinicians are the primary architects of the evidence they create.  Join the Network for Clinical Veracity.  Launch your private Circle today and turn your clinical documentation into a scientific legacy.